Results 91 to 100 of about 524,563 (211)

Alfa-PVP: Why Does Finland Stick Out? [PDF]

Nordisk Alkohol Nark
Hellman M.
europepmc   +1 more source

OxyContin reformulation and drug-related-arrest rates, property-related crimes, child maltreatment and food pantry participation. [PDF]

Front Pharmacol
Zhao H, Sun X.
europepmc   +1 more source

In reply. [PDF]

Oncologist
Mackler ER, Norman S, Jalloul-Rizk F.
europepmc   +1 more source

Game Changers in the Treatment of and Engagement With Persons Living With Mental Health and Substance Use Disorders: The Role of the Nurse. [PDF]

Int J Ment Health Nurs
Kent-Wilkinson A, Ogunwemimo S, Zaba E.
europepmc   +1 more source

Written drug promotion from pharmaceutical companies to general practitioners: adherence to regulations over two decades. [PDF]

Eur J Clin Pharmacol
Almås G, Stangebye M, Slørdal L, Spigset O.   +3 more
europepmc   +1 more source

Reconstructing the professional role of pharmacists in China from the perspective of public value theory: challenges and institutional pathways. [PDF]

J Pharm Policy Pract
Han K, Wu S, Lin F, Nie X, Shi L, Guan X.   +5 more
europepmc   +1 more source

Control by Licensing Over Entry Into the Market [PDF]

, 1941
Bennett, L. T., Jr., Lechliter, Irvin, Silverman, Irwin W.   +2 more
core   +2 more sources

Assessing progress of road safety legislation globally: criteria, methodology and evolution 2015-2023. [PDF]

Inj Prev
Murphy E, Luo F, Auert J.
europepmc   +1 more source

SodiuM glucose cotrANsporter-2 (SGLT-2) inhibitors in the treatment of type II DiAbetes in Tuscany: utiLizatiOn patteRns, and relatEd clinical use evaluation; the MANDALORE study protocol. [PDF]

Front Endocrinol (Lausanne)
Convertino I, Lucenteforte E, Monzillo J, Velo S, Cappello E, Di Cianni G, Penno G, Fornai M.   +7 more
europepmc   +1 more source

Ketamine use and stimulant prescribing: parallel responses to distress. [PDF]

Br J Gen Pract
Fitzpatrick NP.
europepmc   +1 more source